327 related articles for article (PubMed ID: 28975307)
21. Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.
Li Y; Ma J; Jin Y; Li N; Zheng R; Mu W; Wang J; Si JH; Chen J; Shang HC
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012670. PubMed ID: 32108325
[TBL] [Abstract][Full Text] [Related]
22. Neuroleptic dose in the management of delirium in patients with advanced cancer.
Hui D; Bush SH; Gallo LE; Palmer JL; Yennurajalingam S; Bruera E
J Pain Symptom Manage; 2010 Feb; 39(2):186-96. PubMed ID: 20152585
[TBL] [Abstract][Full Text] [Related]
23. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
[TBL] [Abstract][Full Text] [Related]
24. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
[TBL] [Abstract][Full Text] [Related]
25. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
Currier GW; Simpson GM
J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699
[TBL] [Abstract][Full Text] [Related]
26. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Powney MJ; Adams CE; Jones H
Cochrane Database Syst Rev; 2012 Nov; 11():CD009377. PubMed ID: 23152276
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial.
Smit L; Slooter AJC; Devlin JW; Trogrlic Z; Hunfeld NGM; Osse RJ; Ponssen HH; Brouwers AJBW; Schoonderbeek JF; Simons KS; van den Boogaard M; Lens JA; Boer DP; Gommers DAMPJ; Rietdijk WJR; van der Jagt M;
Crit Care; 2023 Oct; 27(1):413. PubMed ID: 37904241
[TBL] [Abstract][Full Text] [Related]
30. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
Bascom PB; Bordley JL; Lawton AJ
Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
[TBL] [Abstract][Full Text] [Related]
31. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW;
N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242
[TBL] [Abstract][Full Text] [Related]
32. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
Isenberg DL; Jacobs D
Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
[TBL] [Abstract][Full Text] [Related]
33. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
[TBL] [Abstract][Full Text] [Related]
34. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
[TBL] [Abstract][Full Text] [Related]
35. Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.
Louis C; Godet T; Chanques G; Bourguignon N; Morand D; Pereira B; Constantin JM;
Trials; 2018 Jun; 19(1):307. PubMed ID: 29866205
[TBL] [Abstract][Full Text] [Related]
36. Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.
Hui D
Curr Opin Support Palliat Care; 2018 Dec; 12(4):489-494. PubMed ID: 30239384
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial.
Stollings JL; Boncyk CS; Birdrow CI; Chen W; Raman R; Gupta DK; Roden DM; Rivera EL; Maiga AW; Rakhit S; Pandharipande PP; Ely EW; Girard TD; Patel MB
JAMA Netw Open; 2024 Jan; 7(1):e2352034. PubMed ID: 38252439
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
Wright P; Meehan K; Birkett M; Lindborg SR; Taylor CC; Morris P; Breier A
Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218
[TBL] [Abstract][Full Text] [Related]
39. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
[TBL] [Abstract][Full Text] [Related]
40. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.
Bieniek SA; Ownby RL; Penalver A; Dominguez RA
Pharmacotherapy; 1998; 18(1):57-62. PubMed ID: 9469682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
